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Management of PE/E: 
Reinforce provider 
capacity
Implementing Components of the Primary 
Health Care Pre-eclampsia/Eclampsia Model in 
Bangladesh: A Cost Analysis
The maternal mortality ratio in Bangladesh, as estimated by the 
2016 Bangladesh Maternal Mortality and Health Care Survey, 
is 172 per 100,000 live births [1]. Pre-eclampsia/Eclampsia 
(PE/E) is the second leading cause of maternal mortality in Ban-
gladesh, accounting for 24% of maternal deaths [2].
PE is identified by high blood pressure and protein in urine with-
in pregnant women after 20 weeks’ gestation. Women with PE 
are at increased risk for organ damage/failure, pre-term birth, 
loss of pregnancy, and stroke. PE can progress to eclampsia, 
which is characterized by seizures, and may be associated with 
kidney and liver damage, as well as maternal death. Infant risks 
include pre-term birth, low birth weight, stillbirth and death, 
among others [2]. Infants born pre-term due to PE are at higher 
risk of long term health issues. The risks of PE/E can be mit-
igated with regular screening during antenatal care (ANC) as 
well as the postnatal period. Once detected, regular monitoring 
of PE can lessen progression to severe PE/E, and severe PE/E 
can be managed through administration of magnesium sulfate 
(MgSO4) and antihypertensive drugs [2].
Between 2016 and 2018, the Population Council, in collabora-
tion with the Directorate General of Family Planning and Obstet-
rical and Gynecological Society of Bangladesh, implemented an 
intervention to confront PE/E that was part of the Ending Ec-
lampsia project, a five-year USAID investment that implemented 
aspects of the Primary Health Care (PHC) PE/E Model in Bangla-
desh, Nigeria, and Pakistan.
The intervention in Bangladesh comprised two components of 
the PHC for PE/E Model: 1) Task sharing to detect and man-
age PE/E (MgSO4 and referral) with PHC providers (Family Wel-
fare Visitors [FWVs], Sub-Assistant Community Medical Officers 
[SACMOs] and Nurse-Midwives), and 2) Introducing antihyper-
tensive drug provision at the PHC level. 
This brief describes the true cost for implementing the two Com-
ponents in Bangladesh and includes a brief description of the 
activities within each Component. Full descriptions of the inter-
vention can be found on the Ending Eclampsia website.
• Component 1 Core task sharing with PHC providers: 451 
providers----52 physicians and 399 PHC providers from 136 
facilities in 12 Upazilas were trained and received monthly 
monitoring support for two years, for a total of USD 241,876 
(BDT 20,220,871). The cost per sub-district was USD 20,156 
(BDT 1,685,073), and the average cost per provider trained 
was USD 536 (BDT 46,284). Actual cost per provider varied.
• Component 2 Introducing antihypertensive drugs at PHCs: 
49 PHC providers were trained through monthly monitoring 
support for 15 months in 31 facilities in two sub-districts, 
for a total of USD 40,066 (BDT 3,349,531). Cost per sub-dis-
trict was USD 20,033 (BDT 1,674,766) and cost per provider 
trained was USD 818 (BDT 68,358).
• Estimates include costs of the project and opportunity 
costs to the Ministry of Health and Family Welfare and to 
participants. Approximately 10% of total costs were cov-
ered by the government and people of Bangladesh
Highlights
COST ANALYSIS METHODOLOGY
The Ending Eclampsia Project in Bangladesh collected ret-
rospective cost data between March and May of 2019. A 
cost ingredient approach first identified each element (in-
put) required to implement activities for components 1 and 
2 of the PHC PE/E Model and then grouped them into cost 
categories: a) personnel, b) supplies, c) infrastructure (here 
defined as office costs and any space used for trainings and 
monitoring visits), d) travel, and e) miscellaneous. For the 
purposes of the cost analysis, orientation sessions were 
considered a separate activity because they were conduct-
ed jointly for both Components 1 and 2. The economic cost 
of each activity was calculated regardless of whether the 
project directly paid for the goods or services. For example, 
to account for the opportunity cost to providers who partici-
pated in a training, their daily wage was calculated although 
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they were not compensated by the project. Estimates for 
training venues under infrastructure and opportunity costs 
were also calculated for rooms donated in-kind by MoHFW 
for some trainings and meeting spaces used for monitor-
ing visits at health facilities. Direct activity costs and project 
management were also captured. 
Cost data were collected from the Ending Eclampsia proj-
ect’s expenditure reports. When cost information was un-
available (such as daily rates), average estimates were pro-
vided by MoHFW representatives. Cost data were generally 
collected in Bangladeshi Taka, in the year purchased, and 
then converted into 2019 USD using the December 31, 
2018 closing exchange rate of 83.6 Bangladeshi Taka per 1 
USD (XE Currency chart). Program management and office 
costs were collected in USD and converted to Bangladeshi 
Taka where necessary, using the same exchange rate. Costs 
per participant and per sub-district were calculated for each 
component. The following section describes the economic 
costs for components 1 and 2 and the orientation sessions.
COMPONENT 1: CORE TASK SHARING 
WITH PHC PROVIDERS
Component 1 comprises task sharing for the prevention, 
detection and management of PE/E at the PHC level us-
ing MgSO4. There were three main activities: 1) training 
Doctors (Gynae consultants and Medical Officers) as train-
ers on the detection and management of PE/E, 2) training 
PHC providers (FWVs, SACMOs, and Nurse/Midwives) on 
administering a loading dose of MgSO4 and referral, and 3) 
routine monitoring support to PHC providers. 
Table 1 lists the costs of replicating Component 1, task 
sharing with PHC providers. The total cost was USD 
241,876 (BDT 20,220,871), with personnel as the larg-
est cost category, followed by infrastructure and travel. Of 
the USD 146,694 in personnel costs, approximately USD 
FIGURE 1: Study sites in Bangladesh
FIGURE 2:  Cost per participant for each activity under Component 1 Core task sharing to the PHC level 
19,197 (8%) were in-kind from MoHFW. Of the USD 54,049 
in infrastructure costs, USD 490 (approximately 1%) were 
also in-kind from MoHFW. Figure 2 shows the cost per par-
ticipant. A total of 451 providers, 52 Medical Officers, and 
399 PHC providers (FWVs, Nurse-midwives, and SACMOs) 
from 136 facilities  in four districts and 12 Upazilas were 
trained. Participants were trained for two days. FWVs and 
nurse-midwives also participated in a one day refresher 
training. The trainings of trainers (ToTs)  were led by the 
Obstetrical and Gynecological Society of Bangladesh and 
Ending Eclampsia staff. PHC provider trainings were led 
by the trained Medical Officers, Ob/Gyn consultants, End-
ing Eclampsia project staff, local program managers, and 
MoHFW staff. 
The average cost per Upazila for Component 1 was USD 
20,156 (BDT 1,739,495) and average cost per provider 
was USD 536 (46,284 BDT). Cost per provider varied by 
activity. In activity 1, 52 doctors participated in a nation-
al-level ToT in the detection and management of PE/E for 
an average of USD 471 (BDT 39,365) per provider. For ac-
tivity 2, doctors from activity 1 trained 399 PHC providers 
to detect PE/E and administer a loading dose of MgSO4 
for an average of USD 301 (BDT 25,163) per provider and 
USD 3,275 (BDT 273, 771) per Upazila. District Monitoring 
Officers (with the support of MoHFW representatives and 
Ending Eclampsia staff) conducted monthly monitoring 
TABLE 1: Cost of core task sharing to PHC level 
visits over approximately two years to 136 facilities. The 
cost per facility was USD 392 (BDT 32, 813) per year, for a 
total of USD 785 (BDT 65,623) for two years.
COMPONENT 2: INTRODUCING              
ANTIHYPERTENSIVE DRUGS AT PHC 
The Ending Eclampsia project introduced task sharing for 
provision of the antihypertensive drug oral alpha methyldopa 
at 31 PHC facilities in two Upazilas. Component 2 included: 
1) training providers to identify and classify hypertension in 
pregnant women, administer antihypertensive drugs, and 
counsel their clients on signs of PE/E, and 2) routine mon-
itoring and support to PHC providers. Table 2 lists the total 
costs for implementing the antihypertensive component, 
USD 40,066 (BDT 3,349,531), with an average cost per 
provider of USD 817 (BDT 68,358). Of the USD 28,061 in 
personnel costs, USD 1,727 (6%) were donated or in-kind, 
and USD 123 of USD 13,529 (a little less than 1%) in in-
frastructure costs were in-kind from the MoHFW. Figure 3 
shows the cost per provider. A total of 49 providers from 31 
facilities participated in a one-day training. Among the 49 
providers, 31 were FWVs and nurse-midwives who also 
participated in a one-day refresher training. These train-
ings were conducted by three trainers and four local pro-
gram managers. The cost per provider was USD 301 (BDT 
25,988). The 31 facilities that participated in the antihy-
pertensive component also received monitoring support. 
TABLE 2: Cost of introducing antihypertensive drugs at 
PHC 






FIGURE 3: Cost per participant and facility under Component 2 introducing antihypertensive drugs at PHC







*Total includes overall program management estimates for the project
*Total includes overall program management estimates for the project
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Monitoring support for antihypertensive administration 
started nine months after Component 1 began and there-
fore lasted for 15 months only. Once Component 2 began, 
monitoring visits for both Components 1 and 2 were done 
jointly  and the costs were shared between the two compo-
nents. The total cost per facility to monitoring under this om-
ponent was USD 823 (BDT 21,328) for the 15 months. Av-
erage cost per Upazila was USD 12,756 (BDT 1,066,423).
CONCLUSION
The economic cost to implement the Ending Eclampsia 
project activities in 136 facilities in 12 Upazilas in Bangla-
desh was USD 312,814 (BDT 26,151,219), or USD 26,068 
(BDTK 2,179,268) per Upazila. In all components, person-
nel was the largest cost category, totaling USD 190,379 
(BDT 15,915,716), accounting for approximately 61% of 
the total costs. Personnel was the largest cost component 
because this was a human resource-based intervention. 
Lessons from implementation of the PE/E PHC Model in 
Bangladesh could lead to cost savings in future interven-
tions. For example, two providers at each PHC facility were 
trained in PE/E management, but since typically only one 
provider is responsible for managing maternal health cas-
es at the PHC level, it may only be necessary to train one 
provider per facility. 
The project directly paid for approximately USD 161,185 
(BDT 134,571) or 85% of the personnel costs captured, 
but it was important to capture the true costs of partici-
pants’ contributions to the project. Health care providers 
were taken away from their health facilities and MoHFW 
staff were unable to partake in other health interventions. 
This analysis, therefore, captured their opportunity costs, 
which accounted for approximately 15% of personnel 
costs. The real opportunity costs to providers, however, 
vary greatly depending upon responsibility and years of ex-
perience. An estimated average was used for this analysis, 
but in reality this cost calculation varies for each provider. 
We also considered estimates for space contributed by 
MoHFW, because those rooms were unavailable for use by 
others during Ending Eclampsia activities. 
Implementation of the PHC-PE/E Model was generally 
phased, starting with Component 1 and followed by Com-
ponent 2. Only the orientation sessions for stakeholders 
and beneficiaries were jointly implemented. Additional 
costs could be saved by implementing these two compo-
nent models concurrently and combining certain activi-
ties. For example, if trainings on use of antihypertensive 
drugs were incorporated into the core component initially, 
implementation costs would be shared and likely reduced. 
To replicate this intervention, infrastructure and travel 
costs will vary, depending if an implementing organization 
or agency had already purchased large equipment and 
could share costs (e.g. vehicles and projectors) among oth-
er activities or would need to rent goods and services. Av-
erage rental costs were used for this analysis for a broader 
cost synopsis, although the cost to the project may have 
been lower. 
Exploring ways to integrate the two components of the 
Ending Eclampsia Model within existing training systems 
should be explored to further reduce costs. This imple-
mentation cost analysis serves as a starting point for 
those considering implementation of different PHC PE/E 
Model components. 
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